Amelia D. Tomlinson

Cutting Edge: <i>Salmonella</i> AvrA Effector Inhibits the Key Proinflammatory, Anti-Apoptotic NF-κB Pathway

Lauren S. Collier-Hyams, Jun Sun, Amelia D. Tomlinson et al. · The Journal of Immunology · 2002 · 278 citations · Full text

Life Sciences, Microbiology, Molecular Biology +17

SER-109, an Investigational Microbiome Drug to Reduce Recurrence After <i>Clostridioides difficile</i> Infection: Lessons Learned From a Phase 2 Trial

Barbara McGovern, Christopher B. Ford, Matthew R. Henn et al. · Clinical Infectious Diseases · 2020 · 158 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +13

A Phase 1b Safety Study of SER-287, a Spore-Based Microbiome Therapeutic, for Active Mild to Moderate Ulcerative Colitis

Matthew R. Henn, Edward J. O’Brien, Liyang Diao et al. · Gastroenterology · 2020 · 109 citations · Full text

Life Sciences, Immunology, Microbiology +17

Agrobacterium tumefaciens ExoR Controls Acid Response Genes and Impacts Exopolysaccharide Synthesis, Horizontal Gene Transfer, and Virulence Gene Expression

Brynn C. Heckel, Amelia D. Tomlinson, Elise R. Morton et al. · Journal of Bacteriology · 2014 · 81 citations · Full text

Life Sciences, Microbiology, Molecular Biology +17

Agrobacterium tumefaciens ExoR represses succinoglycan biosynthesis and is required for biofilm formation and motility

Amelia D. Tomlinson, Bronwyn Ramey-Hartung, Travis W. Day et al. · Microbiology · 2010 · 72 citations · Full text

Agriculture, Microbiology, Molecular Biology +17